TrialJournal of the American College of Cardiology2016

Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.

Robin P Choudhury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.